HAE logo

Haemonetics Corporation (HAE)

Profile

Full Name

Haemonetics Corporation

Ticker

NYSE: HAE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 10, 1991

Indexes

Not included

Website

https://www.haemonetics.com

Employees

3023

Key Details

Price

$74.32(1.13%)

Market Cap

$3.48B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.36B(3.95% YoY)

Annual EPS

$3.31(44.51% YoY)

PE Ratio

21.68

Next earnings date

Feb 5, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $74.32
    HAE price is $74.32

    30-Day Relative Volume

    0.95
    HAE 30-day relative volume is 0.95

    Price Performance

    Price Most Recent Change

    +1.13%
    HAE price was up +1.13% on Nov 17, 2025

    Price YTD Change

    -4.82%
    HAE price is down -4.82% since January 1st

    Price 1-Year Change

    -16.7%
    HAE price is down -16.7% year-on-year

    Price 3-Year Change

    -5.8%
    HAE price is down -5.8% over the past 3 years

    Price Range

    Price All-Time High

    $142.11
    HAE price is currently -47.70% below its historical high of $142.11

    Price 3-Year Low

    $47.32
    HAE price is currently +57.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $3.48B
    HAE market cap is $3.48 billion

    Market Cap 3-Year Change

    -12.88%
    HAE market cap is down -12.88% over the past 3 years

    Market Cap All-Time High

    $7.09B
    HAE market cap is currently -50.92% below its historical high of $7.09 billion

    Market Cap Sector Percentile

    85.37%
    HAE market cap is higher than 85.37% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -6.8%
    HAE shares outstanding is down -6.8% year-on-year

    Shares Outstanding 3-Year Change

    -7.51%
    HAE shares outstanding is down -7.51% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.62
    HAE beta is 0.62

    200-day SMA

    $62.67
    HAE price is currently +18.60% above its 200-day simple moving average

    50-day SMA

    $53.78
    HAE price is currently +38.18% above its 50-day simple moving average

    14-Day RSI

    87.82
    HAE 14-day relative strength index is 87.82

    Volume

    0.95
    HAE 30-day relative volume is 0.95

    ATR

    $2.53
    HAE average true range is $2.53

    10-day Historical Volatility

    156.78%
    HAE 10-day historical volatility is 156.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.36B
    HAE annual revenue is $1.36 billion

    Revenue Analysts Estimate

    $1.32B
    HAE annual revenue is currently +3.35% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +3.95%
    HAE annual revenue is up +3.95% year-on-year

    Revenue Sector Percentile

    87.48%
    HAE annual revenue is higher than 87.48% of companies in Healthcare sector

    EPS

    EPS

    $3.31
    HAE annual earnings per share is $3.31

    EPS Analysts Estimate

    $4.91
    HAE annual earnings per share is currently -32.74% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +44.51%
    HAE annual earnings per share is up +44.51% year-on-year

    EPS Sector Percentile

    93.9%
    HAE annual earnings per share is higher than 93.9% of companies in Healthcare sector

    Profit

    Gross Profit

    $715.33M
    HAE annual gross profit is $715.33 million

    Gross Margin

    52.57%
    HAE annual gross profit margin is 52.57%

    Operating Profit

    $222.34M
    HAE annual operating income is $222.34 million

    Operating Margin

    16.34%
    HAE annual operating profit margin is 16.34%

    Net Income

    $167.68M
    HAE annual net profit is $167.68 million

    Net Margin

    12.32%
    HAE annual net profit margin is 12.32%

    Expenses

    Total Expenses

    $1.19B
    HAE annual total expenses is $1.19 billion

    Operating Expenses

    $492.99M
    HAE annual total operating expenses is $492.99 million

    Cost Of Goods Sold

    $645.50M
    HAE annual cost of goods sold is $645.50 million

    Selling, General & Administrative Expenses

    $436.79M
    HAE annual SG&A is $436.79 million

    Depreciation & Amortization

    $115.59M
    HAE annual D&A is $115.59 million

    Interest Expense

    $0.00
    HAE annual interest expense is $0.00

    Income Tax

    $44.39M
    HAE annual income tax is $44.39 million

    EBIT & EBITDA

    EBIT

    $222.34M
    HAE annual earnings before interest & taxes is $222.34 million

    EBITDA

    $337.93M
    HAE annual EBITDA is $337.93 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $2.45B
    HAE annual total assets is $2.45 billion

    Non Current Assets

    $1.52B
    HAE annual long term assets is $1.52 billion

    Current Assets

    $934.98M
    HAE annual total current assets is $934.98 million

    Cash and Cash Equivalents

    $306.76M
    HAE annual cash & cash equivalents is $306.76 million

    Accounts Receivable

    $202.66M
    HAE annual accounts receivable is $202.66 million

    Inventory

    $365.14M
    HAE annual inventory is $365.14 million

    Liabilities

    Total Liabilities

    $1.63B
    HAE annual total liabilities is $1.63 billion

    Long Term Liabilities

    $80.31M
    HAE annual total long term liabilities is $80.31 million

    Current Liabilities

    $578.11M
    HAE annual current liabilities is $578.11 million

    Accounts Payable

    $67.00M
    HAE annual accounts payable is $67.00 million

    Debt

    Total Debt

    $1.28B
    HAE annual total debt is $1.28 billion

    Total Debt 1-Year Change

    +46.86%
    HAE annual total debt is up +46.86% year-on-year

    Long Term Debt

    $971.68M
    HAE annual long term debt is $971.68 million

    Short Term Debt

    $311.67M
    HAE annual short term debt is $311.67 million

    Equity & Capital

    Shareholders Equity

    $820.84M
    HAE annual stockholders equity is $820.84 million

    Book Value

    $820.84M
    HAE annual book value is $820.84 million

    Retained Earnings

    $352.17M
    HAE annual retained earnings is $352.17 million

    Working Capital

    $356.86M
    HAE annual working capital is $356.86 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $181.72M
    HAE annual cash from operations is $181.72 million

    Cash From Operations 1-Year Change

    -0.01%
    HAE annual cash from operations is down -0.01% year-on-year

    Cash From Investing

    -$161.90M
    HAE annual cash from investing is -$161.90 million

    Cash From Investing 1-Year Change

    +49.78%
    HAE annual cash from investing is up +49.78% year-on-year

    Cash From Financing

    $108.82M
    HAE annual cash from financing is $108.82 million

    Cash From Financing 1-Year Change

    +185.18%
    HAE annual cash from financing is up +185.18% year-on-year

    CAPEX

    CAPEX

    $39.28M
    HAE annual capital expenditures is $39.28 million

    CAPEX 1-Year Change

    -40.75%
    HAE annual capital expenditures is down -40.75% year-on-year

    Free Cash Flow

    Free Cash Flow

    $142.45M
    HAE annual free cash flow is $142.45 million

    Free Cash Flow 1-Year Change

    +23.38%
    HAE annual free cash flow is up +23.38% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    52.57%
    HAE annual gross profit margin is 52.57%

    Operating Margin

    16.34%
    HAE annual operating profit margin is 16.34%

    Net Margin

    12.32%
    HAE annual net profit margin is 12.32%

    ROA & ROE

    ROA

    7.22%
    HAE annual return on assets is 7.22%

    ROE

    18.83%
    HAE annual return on equity is 18.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    21.68
    HAE price to earnings ratio is 21.68

    PE Ratio Sector Percentile

    42.42%
    HAE price to earnings ratio is higher than 42.42% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    4.10
    HAE price to book ratio is 4.10

    PB Ratio Sector Percentile

    71.49%
    HAE price to book ratio is higher than 71.49% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.62
    HAE price to sales ratio is 2.62

    PS Ratio Sector Percentile

    42.77%
    HAE price to sales ratio is higher than 42.77% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $4.41B
    HAE enterprise value is $4.41 billion

    Enterprise Value Sector Percentile

    86.68%
    HAE enterprise value is higher than 86.68% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    12.57
    HAE EV/EBITDA is 12.57

    EV/EBITDA Sector Percentile

    85.17%
    HAE EV/EBITDA is higher than 85.17% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.62
    HAE annual current ratio is 1.62

    Quick Ratio

    0.99
    HAE annual quick ratio is 0.99

    Leverage

    Debt To Equity

    1.56
    HAE annual debt to equity ratio is 1.56

    Interest Coverage Ratio

    -
    HAE annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    7
    HAE piotroski f-score is 7

    Altman Z-Score

    2.51
    HAE altman z-score is 2.51

    Analyst ratings

    Recent major analysts updates

    Nov 7, 25 Needham
    Buy
    Nov 7, 25 Barrington Research
    Outperform
    Nov 6, 25 BTIG
    Buy
    Oct 21, 25 Barrington Research
    Outperform
    Oct 7, 25 Citigroup
    Buy
    Sep 23, 25 Barrington Research
    Outperform
    Aug 11, 25 Raymond James
    Outperform
    Aug 8, 25 Mizuho
    Outperform
    Aug 8, 25 JP Morgan
    Neutral
    Aug 8, 25 Barrington Research
    Outperform

    Institutional Ownership

    Screeners with HAE included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Stocks with high RSI
    • What is the ticker symbol for Haemonetics Corporation?
    • Does Haemonetics Corporation pay dividends?
    • What sector is Haemonetics Corporation in?
    • What industry is Haemonetics Corporation in?
    • What country is Haemonetics Corporation based in?
    • When did Haemonetics Corporation go public?
    • Is Haemonetics Corporation in the S&P 500?
    • Is Haemonetics Corporation in the NASDAQ 100?
    • Is Haemonetics Corporation in the Dow Jones?
    • When was Haemonetics Corporation's last earnings report?
    • When does Haemonetics Corporation report earnings?

    What is the ticker symbol for Haemonetics Corporation?

    The ticker symbol for Haemonetics Corporation is NYSE:HAE

    Does Haemonetics Corporation pay dividends?

    No, Haemonetics Corporation does not pay dividends

    What sector is Haemonetics Corporation in?

    Haemonetics Corporation is in the Healthcare sector

    What industry is Haemonetics Corporation in?

    Haemonetics Corporation is in the Medical Devices industry

    What country is Haemonetics Corporation based in?

    Haemonetics Corporation is headquartered in United States

    When did Haemonetics Corporation go public?

    Haemonetics Corporation's initial public offering (IPO) was on May 10, 1991

    Is Haemonetics Corporation in the S&P 500?

    No, Haemonetics Corporation is not included in the S&P 500 index

    Is Haemonetics Corporation in the NASDAQ 100?

    No, Haemonetics Corporation is not included in the NASDAQ 100 index

    Is Haemonetics Corporation in the Dow Jones?

    No, Haemonetics Corporation is not included in the Dow Jones index

    When was Haemonetics Corporation's last earnings report?

    Haemonetics Corporation's most recent earnings report was on November 6, 2025

    When does Haemonetics Corporation report earnings?

    The next expected earnings date for Haemonetics Corporation is February 5, 2026
    On this page